242 related articles for article (PubMed ID: 1468291)
1. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo.
Steed DL; Goslen JB; Holloway GA; Malone JM; Bunt TJ; Webster MW
Diabetes Care; 1992 Nov; 15(11):1598-604. PubMed ID: 1468291
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report.
Krupski WC; Reilly LM; Perez S; Moss KM; Crombleholme PA; Rapp JH
J Vasc Surg; 1991 Oct; 14(4):526-32; discussion 532-6. PubMed ID: 1920650
[TBL] [Abstract][Full Text] [Related]
3. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.
Richard JL; Parer-Richard C; Daures JP; Clouet S; Vannereau D; Bringer J; Rodier M; Jacob C; Comte-Bardonnet M
Diabetes Care; 1995 Jan; 18(1):64-9. PubMed ID: 7698050
[TBL] [Abstract][Full Text] [Related]
4. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers.
Martínez-de Jesús FR; Morales-Guzmán M; Castañeda M; Pérez-Morales A; García-Alonso J; Mendiola-Segura I
Arch Med Res; 1997; 28(1):95-9. PubMed ID: 9078595
[TBL] [Abstract][Full Text] [Related]
5. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
6. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
Kalani M; Apelqvist J; Blombäck M; Brismar K; Eliasson B; Eriksson JW; Fagrell B; Hamsten A; Torffvit O; Jörneskog G
Diabetes Care; 2003 Sep; 26(9):2575-80. PubMed ID: 12941721
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers.
Senet P; Bon FX; Benbunan M; Bussel A; Traineau R; Calvo F; Dubertret L; Dosquet C
J Vasc Surg; 2003 Dec; 38(6):1342-8. PubMed ID: 14681639
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
[TBL] [Abstract][Full Text] [Related]
9. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
O'Meara S; Cullum N; Majid M; Sheldon T
Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
[TBL] [Abstract][Full Text] [Related]
10. A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study.
Frykberg RG; Franks PJ; Edmonds M; Brantley JN; Téot L; Wild T; Garoufalis MG; Lee AM; Thompson JA; Reach G; Dove CR; Lachgar K; Grotemeyer D; Renton SC;
Diabetes Care; 2020 Mar; 43(3):616-624. PubMed ID: 31619393
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
Wieman TJ; Smiell JM; Su Y
Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
[TBL] [Abstract][Full Text] [Related]
12. Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial.
Ma C; Hernandez MA; Kirkpatrick VE; Liang LJ; Nouvong AL; Gordon II
Wounds; 2015 Apr; 27(4):83-91. PubMed ID: 25855851
[TBL] [Abstract][Full Text] [Related]
13. [Questionable effectiveness of autologous platelet growth factors (PDWHF) in treatment of venous ulcers of the leg].
Reutter H; Bort S; Jung MF; Klyscz T; Schippert W; Zuder D; Jünger M
Hautarzt; 1999 Dec; 50(12):859-65. PubMed ID: 10663020
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth factor enhances healing of diabetic foot ulcers.
Tsang MW; Wong WK; Hung CS; Lai KM; Tang W; Cheung EY; Kam G; Leung L; Chan CW; Chu CM; Lam EK
Diabetes Care; 2003 Jun; 26(6):1856-61. PubMed ID: 12766123
[TBL] [Abstract][Full Text] [Related]
15. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial.
Park KH; Han SH; Hong JP; Han SK; Lee DH; Kim BS; Ahn JH; Lee JW
Diabetes Res Clin Pract; 2018 Aug; 142():335-344. PubMed ID: 29902542
[TBL] [Abstract][Full Text] [Related]
16. A Randomized, Controlled Trial to Assess the Effect of Topical Insulin Versus Normal Saline in Pressure Ulcer Healing.
Stephen S; Agnihotri M; Kaur S
Ostomy Wound Manage; 2016 Jun; 62(6):16-23. PubMed ID: 27356143
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.
Hanft JR; Pollak RA; Barbul A; van Gils C; Kwon PS; Gray SM; Lynch CJ; Semba CP; Breen TJ
J Wound Care; 2008 Jan; 17(1):30-2, 34-7. PubMed ID: 18210954
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ornithine alpha-ketoglutarate in heel pressure ulcers in elderly patients: results of a randomized controlled trial.
Meaume S; Kerihuel JC; Constans T; Teot L; Lerebours E; Kern J; Bourdel Marchasson I
J Nutr Health Aging; 2009 Aug; 13(7):623-30. PubMed ID: 19621198
[TBL] [Abstract][Full Text] [Related]
19. Recurrence rate of diabetic neurotrophic foot ulcers healed using topical application of growth factors released from platelets.
Steed DL; Edington HD; Webster MW
Wound Repair Regen; 1996; 4(2):230-3. PubMed ID: 17177818
[TBL] [Abstract][Full Text] [Related]
20. Visible light-induced healing of diabetic or venous foot ulcers: a placebo-controlled double-blind study.
Landau Z; Migdal M; Lipovsky A; Lubart R
Photomed Laser Surg; 2011 Jun; 29(6):399-404. PubMed ID: 21214497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
